SCHEMBL16019810

SCHEMBL16019810

Cc1cc2c(cc1-c1ccc(NC(=O)c3c(C)noc3C(C)C)cc1)OC(F)(F)O2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ GAA P10253 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.39
▸ ADORA2A P29274 1/20 0.39
▸ ADORA2B P29275 1/20 0.39
▸ ADORA1 P30542 1/20 0.39
▸ GFER P55789 1/20 0.39
▸ SCN9A Q15858 1/20 0.39
▸ STIM1 Q13586 1/20 0.39
▸ ORAI1 Q96D31 1/20 0.39
▸ TRPA1 O75762 1/20 0.38
▸ FLT1 P17948 1/20 0.38
▸ KDR P35968 1/20 0.38
▸ IL2 P60568 2/20 0.38
▸ TAS2R8 Q9NYW2 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14887766 0.92 CYP1A2 (0.43) CYP1A2CYP2C9SMN1; SMN2GAANPC1
SCHEMBL16020153 0.90 SMN1; SMN2 (0.43) CYP1A2CYP2C9SMN1; SMN2GAANPC1
SCHEMBL16020577 0.89 STIM1 (0.48) CYP2C9ADORA3ADORA2AADORA2BADORA1
SCHEMBL14881326 0.88 GFER (0.52) CYP1A2CYP2C9GAANPC1RAB9A
SCHEMBL14887768 0.84 TP53 (0.40) SMN1; SMN2ADORA3ADORA2AADORA2BADORA1
SCHEMBL16019806 0.84 RXFP1 (0.43) CYP1A2CYP2C9SMN1; SMN2GAANPC1
SCHEMBL16017278 0.84 SCN9A (0.40) SMN1; SMN2NPC1RAB9AADORA3ADORA2A
SCHEMBL16020152 0.83 STIM1 (0.43) CYP1A2CYP2C9SMN1; SMN2GAANPC1
SCHEMBL14885668 0.81 STIM1 (0.48) CYP2C9ADORA3ADORA2AADORA2BADORA1
SCHEMBL14885687 0.81 STIM1 (0.54) STIM1ORAI1TRPA1IL2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. 2014-09-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140256771-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 CYP1A2 4570/4885CYP2C9 4656/4885SMN1; SMN2 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback